Pms64 - Multiple Sclerosis and Workability in Italy: The Economic Effect of Natalizumab on the Ability to Work
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1778
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV